Join us for an insightful webinar exploring the evolving regulatory landscape shaping the future of cell and gene therapies (CGTs). This expert-led session will dive into recent and anticipated regulatory decisions and their far-reaching implications for CGT development, approval, and commercialization.Attendees will gain a global perspective on how collaboration between regulatory agencies is driving alignment and accelerating patient access to advanced therapies. The panel will also examine innovative regulatory strategies, highlighting creative approaches to clinical trial design, selection of endpoints, strategic use of regulatory designations, and integration of real-world longitudinal data to support product development and approval.With firsthand insights from experienced regulatory professionals, the discussion will also provide actionable guidance for CGT developers and sponsors on how to proactively manage and minimize regulatory risks. Whether you are navigating early-stage development or preparing for submission, this webinar offers a comprehensive overview of the tools, partnerships, and regulatory pathways that can streamline progress and enhance the likelihood of success in this fast-moving field. Tune in to keep up and stay ahead in the dynamic world of CGT regulations.